Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study

Current evidence of an association between body size and prostate cancer is conflicting, possibly due to differential effects of body size across the lifespan and the heterogeneity of the disease. We therefore examined childhood and adult body size in relation to total incident prostate cancer and p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2016-02, Vol.138 (4), p.853-865
Hauptverfasser: Möller, Elisabeth, Wilson, Kathryn M., Batista, Julie L., Mucci, Lorelei A., Bälter, Katarina, Giovannucci, Edward
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 865
container_issue 4
container_start_page 853
container_title International journal of cancer
container_volume 138
creator Möller, Elisabeth
Wilson, Kathryn M.
Batista, Julie L.
Mucci, Lorelei A.
Bälter, Katarina
Giovannucci, Edward
description Current evidence of an association between body size and prostate cancer is conflicting, possibly due to differential effects of body size across the lifespan and the heterogeneity of the disease. We therefore examined childhood and adult body size in relation to total incident prostate cancer and prognostic subtypes in a prospective cohort of 47,491 US men in the Health Professionals Follow‐up Study. We assessed adult height, body mass index (BMI) in early and middle‐to‐late adulthood, adult waist circumference, and body shape at age 10. With follow‐up from 1986 to 2010, we estimated the relative risk (RR) of prostate cancer using Cox proportional hazards models. We identified 6,183 incident cases. Tallness was associated with increased risk of advanced‐stage tumors, particularly fatal disease (RR = 1.66, 95% CI 1.23–2.23, highest vs. lowest quintile, ptrend 
doi_str_mv 10.1002/ijc.29842
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_510809</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760910521</sourcerecordid><originalsourceid>FETCH-LOGICAL-j5802-557c577688e5480eeb9aa848e97b73bbea596baef59e84db70fce642c5b095f03</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxi1ERZfCgRdAlrj00LRjJ_6TC1LZUtqqEkj8uVp2Mul6ycZLnHS1nHgEnpEnwd1dKorEyaPv-3n0aWYIecHgmAHwEz-vjnmpC_6ITBiUKgPOxGMySR5kiuVynzyNcQ7AmIDiCdnnMhdCg5wQ9ybUaxr9d6S26kOMdJghbX2DtApjH5Pc1XSZnMEOSbNdhT313Qa7QNsOM_qhDw3G6ENn20jPQ9uG1a8fP8cl_TiM9foZ2WuSgc937wH5fP720_Qiu37_7nJ6ep3NUxSeCaEqoZTUGkWhAdGV1upCY6mcyp1DK0rpLDaiRF3UTkFToSx4JRyUooH8gGTbvnGFy9GZZe8Xtl-bYL3ZSV9ThUYw0FAm_ui__Jn_cmpCf2MW9cwUIKVO-OstntgF1hV2Q2_bB78eOp2fmZtwa9LIeV7I1OBw16AP30aMg1n4WGHb2g7DGA1TEkoGgrOEvvoHnadl3I03UUIJEEzniXr5d6L7KH-2m4CTLbDyLa7vfQbm7mxMOhuzORtzeTXdFPlvI4O3Wg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757505183</pqid></control><display><type>article</type><title>Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><creator>Möller, Elisabeth ; Wilson, Kathryn M. ; Batista, Julie L. ; Mucci, Lorelei A. ; Bälter, Katarina ; Giovannucci, Edward</creator><creatorcontrib>Möller, Elisabeth ; Wilson, Kathryn M. ; Batista, Julie L. ; Mucci, Lorelei A. ; Bälter, Katarina ; Giovannucci, Edward</creatorcontrib><description>Current evidence of an association between body size and prostate cancer is conflicting, possibly due to differential effects of body size across the lifespan and the heterogeneity of the disease. We therefore examined childhood and adult body size in relation to total incident prostate cancer and prognostic subtypes in a prospective cohort of 47,491 US men in the Health Professionals Follow‐up Study. We assessed adult height, body mass index (BMI) in early and middle‐to‐late adulthood, adult waist circumference, and body shape at age 10. With follow‐up from 1986 to 2010, we estimated the relative risk (RR) of prostate cancer using Cox proportional hazards models. We identified 6,183 incident cases. Tallness was associated with increased risk of advanced‐stage tumors, particularly fatal disease (RR = 1.66, 95% CI 1.23–2.23, highest vs. lowest quintile, ptrend &lt; 0.001). High BMI at age 21 was inversely associated with total prostate cancer (RR = 0.89, 95% CI 0.80–0.98, BMI ≥26 vs. 20–21.9, ptrend = 0.01) and with fatal and advanced disease. The association for late adult BMI differed by age (pinteraction &lt; 0.001); high BMI was inversely associated with total prostate cancer (RR = 0.64, 95% CI 0.51–0.78, BMI ≥30 vs. 21–22.9, ptrend&lt;0.001) and with non‐advanced and less aggressive tumors among men ≤65 years, whereas no association was seen among men &gt;65 years. Adult waist circumference was weakly inversely associated with less aggressive disease. Childhood obesity was unclearly related to risk. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. The influence of adiposity varies by prognostic disease subtype and by age. The relationship between body size and prostate cancer is complex. Body size changes progressively throughout life and consequent effects on prostate cancer risk may be associated with related changes in hormonal and metabolic pathways. This large prospective study examined potential associations between the risk of various prostate cancer subtypes and multiple anthropometric measures at different ages in men. Tallness was confirmed to be associated with an elevated risk of advanced prostate cancer, particularly fatal disease. The extent to which body weight influenced risk varied according to factors such as age and disease subtype. What's new? The relationship between body size and prostate cancer is complex. In one of the largest prospective studies on men, we examined the association between multiple anthropometric measures at different ages and risk of various prostate cancer subtypes. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. We also found that the influence of adiposity varies strongly by age and disease subtype, which is fundamental for future studies.</description><identifier>ISSN: 0020-7136</identifier><identifier>ISSN: 1097-0215</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.29842</identifier><identifier>PMID: 26355806</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Age ; Aged ; Anthropometry ; Body Mass Index ; Body Size - physiology ; Cancer ; childhood body size ; epidemiology ; Follow-Up Studies ; Health risk assessment ; height ; Humans ; Incidence ; Male ; Medical personnel ; Medical research ; Mens health ; Middle Aged ; Proportional Hazards Models ; Prostate cancer ; prostatic neoplasms ; Prostatic Neoplasms - epidemiology ; Risk Factors ; Tumors ; waist circumference ; Young Adult</subject><ispartof>International journal of cancer, 2016-02, Vol.138 (4), p.853-865</ispartof><rights>2015 UICC</rights><rights>2015 UICC.</rights><rights>2016 UICC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.29842$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.29842$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,550,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26355806$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-40668$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:132859052$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Möller, Elisabeth</creatorcontrib><creatorcontrib>Wilson, Kathryn M.</creatorcontrib><creatorcontrib>Batista, Julie L.</creatorcontrib><creatorcontrib>Mucci, Lorelei A.</creatorcontrib><creatorcontrib>Bälter, Katarina</creatorcontrib><creatorcontrib>Giovannucci, Edward</creatorcontrib><title>Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Current evidence of an association between body size and prostate cancer is conflicting, possibly due to differential effects of body size across the lifespan and the heterogeneity of the disease. We therefore examined childhood and adult body size in relation to total incident prostate cancer and prognostic subtypes in a prospective cohort of 47,491 US men in the Health Professionals Follow‐up Study. We assessed adult height, body mass index (BMI) in early and middle‐to‐late adulthood, adult waist circumference, and body shape at age 10. With follow‐up from 1986 to 2010, we estimated the relative risk (RR) of prostate cancer using Cox proportional hazards models. We identified 6,183 incident cases. Tallness was associated with increased risk of advanced‐stage tumors, particularly fatal disease (RR = 1.66, 95% CI 1.23–2.23, highest vs. lowest quintile, ptrend &lt; 0.001). High BMI at age 21 was inversely associated with total prostate cancer (RR = 0.89, 95% CI 0.80–0.98, BMI ≥26 vs. 20–21.9, ptrend = 0.01) and with fatal and advanced disease. The association for late adult BMI differed by age (pinteraction &lt; 0.001); high BMI was inversely associated with total prostate cancer (RR = 0.64, 95% CI 0.51–0.78, BMI ≥30 vs. 21–22.9, ptrend&lt;0.001) and with non‐advanced and less aggressive tumors among men ≤65 years, whereas no association was seen among men &gt;65 years. Adult waist circumference was weakly inversely associated with less aggressive disease. Childhood obesity was unclearly related to risk. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. The influence of adiposity varies by prognostic disease subtype and by age. The relationship between body size and prostate cancer is complex. Body size changes progressively throughout life and consequent effects on prostate cancer risk may be associated with related changes in hormonal and metabolic pathways. This large prospective study examined potential associations between the risk of various prostate cancer subtypes and multiple anthropometric measures at different ages in men. Tallness was confirmed to be associated with an elevated risk of advanced prostate cancer, particularly fatal disease. The extent to which body weight influenced risk varied according to factors such as age and disease subtype. What's new? The relationship between body size and prostate cancer is complex. In one of the largest prospective studies on men, we examined the association between multiple anthropometric measures at different ages and risk of various prostate cancer subtypes. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. We also found that the influence of adiposity varies strongly by age and disease subtype, which is fundamental for future studies.</description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Anthropometry</subject><subject>Body Mass Index</subject><subject>Body Size - physiology</subject><subject>Cancer</subject><subject>childhood body size</subject><subject>epidemiology</subject><subject>Follow-Up Studies</subject><subject>Health risk assessment</subject><subject>height</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical personnel</subject><subject>Medical research</subject><subject>Mens health</subject><subject>Middle Aged</subject><subject>Proportional Hazards Models</subject><subject>Prostate cancer</subject><subject>prostatic neoplasms</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Risk Factors</subject><subject>Tumors</subject><subject>waist circumference</subject><subject>Young Adult</subject><issn>0020-7136</issn><issn>1097-0215</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp1ks9u1DAQxi1ERZfCgRdAlrj00LRjJ_6TC1LZUtqqEkj8uVp2Mul6ycZLnHS1nHgEnpEnwd1dKorEyaPv-3n0aWYIecHgmAHwEz-vjnmpC_6ITBiUKgPOxGMySR5kiuVynzyNcQ7AmIDiCdnnMhdCg5wQ9ybUaxr9d6S26kOMdJghbX2DtApjH5Pc1XSZnMEOSbNdhT313Qa7QNsOM_qhDw3G6ENn20jPQ9uG1a8fP8cl_TiM9foZ2WuSgc937wH5fP720_Qiu37_7nJ6ep3NUxSeCaEqoZTUGkWhAdGV1upCY6mcyp1DK0rpLDaiRF3UTkFToSx4JRyUooH8gGTbvnGFy9GZZe8Xtl-bYL3ZSV9ThUYw0FAm_ui__Jn_cmpCf2MW9cwUIKVO-OstntgF1hV2Q2_bB78eOp2fmZtwa9LIeV7I1OBw16AP30aMg1n4WGHb2g7DGA1TEkoGgrOEvvoHnadl3I03UUIJEEzniXr5d6L7KH-2m4CTLbDyLa7vfQbm7mxMOhuzORtzeTXdFPlvI4O3Wg</recordid><startdate>20160215</startdate><enddate>20160215</enddate><creator>Möller, Elisabeth</creator><creator>Wilson, Kathryn M.</creator><creator>Batista, Julie L.</creator><creator>Mucci, Lorelei A.</creator><creator>Bälter, Katarina</creator><creator>Giovannucci, Edward</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF7</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20160215</creationdate><title>Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study</title><author>Möller, Elisabeth ; Wilson, Kathryn M. ; Batista, Julie L. ; Mucci, Lorelei A. ; Bälter, Katarina ; Giovannucci, Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j5802-557c577688e5480eeb9aa848e97b73bbea596baef59e84db70fce642c5b095f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Anthropometry</topic><topic>Body Mass Index</topic><topic>Body Size - physiology</topic><topic>Cancer</topic><topic>childhood body size</topic><topic>epidemiology</topic><topic>Follow-Up Studies</topic><topic>Health risk assessment</topic><topic>height</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical personnel</topic><topic>Medical research</topic><topic>Mens health</topic><topic>Middle Aged</topic><topic>Proportional Hazards Models</topic><topic>Prostate cancer</topic><topic>prostatic neoplasms</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Risk Factors</topic><topic>Tumors</topic><topic>waist circumference</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Möller, Elisabeth</creatorcontrib><creatorcontrib>Wilson, Kathryn M.</creatorcontrib><creatorcontrib>Batista, Julie L.</creatorcontrib><creatorcontrib>Mucci, Lorelei A.</creatorcontrib><creatorcontrib>Bälter, Katarina</creatorcontrib><creatorcontrib>Giovannucci, Edward</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Mälardalens högskola</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Möller, Elisabeth</au><au>Wilson, Kathryn M.</au><au>Batista, Julie L.</au><au>Mucci, Lorelei A.</au><au>Bälter, Katarina</au><au>Giovannucci, Edward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2016-02-15</date><risdate>2016</risdate><volume>138</volume><issue>4</issue><spage>853</spage><epage>865</epage><pages>853-865</pages><issn>0020-7136</issn><issn>1097-0215</issn><eissn>1097-0215</eissn><abstract>Current evidence of an association between body size and prostate cancer is conflicting, possibly due to differential effects of body size across the lifespan and the heterogeneity of the disease. We therefore examined childhood and adult body size in relation to total incident prostate cancer and prognostic subtypes in a prospective cohort of 47,491 US men in the Health Professionals Follow‐up Study. We assessed adult height, body mass index (BMI) in early and middle‐to‐late adulthood, adult waist circumference, and body shape at age 10. With follow‐up from 1986 to 2010, we estimated the relative risk (RR) of prostate cancer using Cox proportional hazards models. We identified 6,183 incident cases. Tallness was associated with increased risk of advanced‐stage tumors, particularly fatal disease (RR = 1.66, 95% CI 1.23–2.23, highest vs. lowest quintile, ptrend &lt; 0.001). High BMI at age 21 was inversely associated with total prostate cancer (RR = 0.89, 95% CI 0.80–0.98, BMI ≥26 vs. 20–21.9, ptrend = 0.01) and with fatal and advanced disease. The association for late adult BMI differed by age (pinteraction &lt; 0.001); high BMI was inversely associated with total prostate cancer (RR = 0.64, 95% CI 0.51–0.78, BMI ≥30 vs. 21–22.9, ptrend&lt;0.001) and with non‐advanced and less aggressive tumors among men ≤65 years, whereas no association was seen among men &gt;65 years. Adult waist circumference was weakly inversely associated with less aggressive disease. Childhood obesity was unclearly related to risk. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. The influence of adiposity varies by prognostic disease subtype and by age. The relationship between body size and prostate cancer is complex. Body size changes progressively throughout life and consequent effects on prostate cancer risk may be associated with related changes in hormonal and metabolic pathways. This large prospective study examined potential associations between the risk of various prostate cancer subtypes and multiple anthropometric measures at different ages in men. Tallness was confirmed to be associated with an elevated risk of advanced prostate cancer, particularly fatal disease. The extent to which body weight influenced risk varied according to factors such as age and disease subtype. What's new? The relationship between body size and prostate cancer is complex. In one of the largest prospective studies on men, we examined the association between multiple anthropometric measures at different ages and risk of various prostate cancer subtypes. Our study confirms tall men to be at increased risk of fatal and advanced prostate cancer. We also found that the influence of adiposity varies strongly by age and disease subtype, which is fundamental for future studies.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>26355806</pmid><doi>10.1002/ijc.29842</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2016-02, Vol.138 (4), p.853-865
issn 0020-7136
1097-0215
1097-0215
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_510809
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online
subjects Adult
Age
Aged
Anthropometry
Body Mass Index
Body Size - physiology
Cancer
childhood body size
epidemiology
Follow-Up Studies
Health risk assessment
height
Humans
Incidence
Male
Medical personnel
Medical research
Mens health
Middle Aged
Proportional Hazards Models
Prostate cancer
prostatic neoplasms
Prostatic Neoplasms - epidemiology
Risk Factors
Tumors
waist circumference
Young Adult
title Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A12%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Body%20size%20across%20the%20life%20course%20and%20prostate%20cancer%20in%20the%20Health%20Professionals%20Follow%E2%80%90up%20Study&rft.jtitle=International%20journal%20of%20cancer&rft.au=M%C3%B6ller,%20Elisabeth&rft.date=2016-02-15&rft.volume=138&rft.issue=4&rft.spage=853&rft.epage=865&rft.pages=853-865&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.29842&rft_dat=%3Cproquest_swepu%3E1760910521%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1757505183&rft_id=info:pmid/26355806&rfr_iscdi=true